Proteins and peptides: The need to improve them as promising therapeutics for ulcerative colitis. (17th February 2016)

• Record Type: Journal Article
• Authors: Sahu, Kantrol Kumar; Minz, Sunita; Kaurav, Monika; Pandey, Ravi Shankar
• Is Part Of: Artificial cells, nanomedicine, and biotechnology. Volume 44:Number 2(2016)
• Page Start: 642
• Page End: 653
• Publication Date: 2016-02-17
• Subjects: inflammatory bowel disease -- therapeutic proteins -- therapeutic peptides -- ulcerative colitis; Artificial cells -- Periodicals; Nanotechnology -- Periodicals; Blood substitutes -- Periodicals; Tissue engineering -- Periodicals; Molecules -- Periodicals; Biotechnology -- Periodicals; 615.39
• DOI: 10.3109/21691401.2014.975239
• Languages: English
• ISSNs: 2169-1401

Abstract

Abstract : The present review briefly describes the nature, type and pathogenesis of ulcerative colitis, and explores the potential use of peptides and proteins in the treatment of inflammatory bowel disease, especially ulcerative colitis. Intestinal absorption and the barrier mechanism of peptide and protein drugs are also discussed, with special emphasis on various strategies which make these drugs better therapeutics having high specificity, potency and molecular targeting ability. However, the limitation of such therapeutics are oral administration, poor pharmacokinetic profile and decreased bioavailability. The recent findings illustrated in this review will be helpful in designing the peptide/protein drugs as a promising treatment of choice for ulcerative colitis.